Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.445 USD | -0.34% | -9.12% | +8.65% |
06-14 | Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform | CI |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.65% | 45.35M | |
-34.21% | 14.7B | |
-52.07% | 2.33B | |
+23.01% | 1.96B | |
-10.06% | 1.52B | |
+21.24% | 1.24B | |
-23.46% | 904M | |
+1.33% | 784M | |
-34.13% | 750M | |
+23.58% | 597M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- HC Wainwright Adjusts Price Target on Co-Diagnostics to $3 From $2, Maintains Neutral Rating